Approval · Notice of Compliance 20164 · 2017
KANUMA: Notice of Compliance 20164
Issued December 15, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 20164
- Date
- December 15, 2017
- Company
- Alexion Pharma GmbhBaar, --, Switzerland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KANUMA | 02469596 | Marketed |
Medicinal ingredients
- SEBELIPASE ALFA 2 MG per ML